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Introduction 
Prostate cancer is the second most common cancer in men worldwide.  Curative therapies for clinically localized 
prostate cancer include surgery, radiation therapy and brachytherapy.  One randomized control trial has however 
shown that high dose rate brachytherapy (HDR-BT), when given in conjunction with external beam radiotherapy 
(EBRT), is more effective than EBRT alone
1
.
 
 The goal of this study was to compare the results of curative HDR-BT 
with EBRT against EBRT alone.  
Materials and Methods
 
A retrospective chart review was completed on a sample of 324 patients who were treated at a regional cancer 
centre in southwestern Ontario between 2001 and 2014. These patients were classified as high-risk according to 
the American Urological Association and European Association of Urology of having clinical or pathological staging 
T2c/T3a or Gleason score of 8-10 or Prostate Specific Antigen (PSA) ≥ 20 ng/mL. Of the 324 patients, 53 received 
HDR-BT with EBRT and 271 received EBRT only.  Relapse was defined using the Phoenix definition of PSA rise 2 
ng/mL above the nadir.  The primary and secondary endpoints of the study were relapse free survival (RFS) and 
overall survival (OS). 
Results 
The mean age of the study sample was 78 years (SD ± 8.1) with a mean pre-treament PSA of 17.98 (SD ± 15.79). 
While relapse occurred in 43 of the 271 patients who received EBRT, only 3 of the 53 patients who received HDR 
relapsed. Kaplan Meier survival analysis suggested that by the end of the 5 year follow up, more than 50% of 
patients in each of the study groups were relapse free; and thus median survival was not calculable. The mean 
time to relapse between the EBRT and HDR groups was (53.7 and 58.5 months, respectively; Log rank = 3.82, p = 
0.05).  
Conclusion 
Patients who underwent HDR-BT compared to EBRT had a higher RFS and OS.  Time to relapse was lower in 
patients who underwent EBRT when compared to HDR-BT. Further analysis on a larger sample is warranted given 
the limited number of HDR patients in our study. 
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